tm logo
ZYGEL
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 07 Mar 2022

Last Applicant/ Owned by

80 W. Lancaster Avenue, Suite 300

Devon

PA

19333

Serial Number

87571145 filed on 16th Aug 2017

Registration Number

N/A

Correspondent Address

Sarah Anne Keefe

Womble Bond Dickinson (US) LLP

Independence Wharf

470 Atlantic Avenue, Suite 600

BOSTON MA 02210

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ZYGEL

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases andRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders

Mark Details


Serial Number

No 87571145

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 103015.192.4

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th Mar 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
07th Mar 2022ABANDONMENT - NO USE STATEMENT FILED
13th Jul 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Jul 2021EXTENSION 5 GRANTED
08th Jul 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
30th Jun 2021EXTENSION 5 FILED
30th Jun 2021TEAS EXTENSION RECEIVED
06th Jan 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04th Jan 2021EXTENSION 4 GRANTED
04th Jan 2021EXTENSION 4 FILED